Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series A
Biotech
Braveheart, with Biogen CEO on board, rallies $185M series A
The biotech is led by former HI-Bio founder and CEO Travis Murdoch, M.D., while Biogen's CEO Chris Viehbacher chairs the board of directors.
Zoey Becker
Nov 5, 2025 7:51am
Fierce Biotech Fundraising Tracker: Braveheart, Azalea & more
Nov 5, 2025 6:33am
In vivo gene editing biotech blossoms from Jennifer Doudna's lab
Nov 4, 2025 8:00am
Zag Bio emerges with $80M funding for Tregs diabetes candidate
Oct 28, 2025 7:00am
British biotech elevates with $70M and midstage arthritis asset
Oct 21, 2025 7:01pm
French antibody biotech draws in $122M for push to clinic
Oct 16, 2025 11:19am
